The Sechenov University of Russia has claimed to have successfully completed the clinical trials of the COVID-19 vaccine on humans and the results have proven the medication’s effectiveness. The volunteers who took the shot in two batches will be discharged on July 15th and July 20th.
The researchers claimed that volunteers of the first and second groups are forming an immune response after injections of the vaccine against the coronavirus. The vaccine should now get the approvals for mass production. However, most countries and the WHO is likely to disapprove of this claim.
Most countries would consider the so-called trial only as Phase-1. The vaccine has to be tested on hundreds of participants in Phase-2 while on thousands of people in the Phase-3. Even considering the urgency of the vaccine, no country would risk approving the Vaccine before the completion of Phase-3 limited trials.
So, it is going to be a long way to go before the vaccine candidate is authorized for distribution. According to the same WHO document, the only vaccine candidates to have reached Phase III trials were the University of Oxford/Astra Zeneca’s and China’s Sinovac’s.
